X
ACHEMA MIDDLE EAST 2026
Pharma Advancement
DDF Summit 2025
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    idiopathic pulmonary fibrosis

    US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

    Tissue Repair Drug

    FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

    FastTrack Review

    US FDA Launches Fast-Track Review Scheme for Generic Drugs

    AI Based Drug Discovery

    Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

    wearable drug delivery devices

    Wearable Drug Delivery Devices for On-Demand Care

    biologic drug formulation stability

    Breakthroughs in Biologic Drug Formulation Stability

    high volume injectable formulations

    Overcoming Challenges in High-Volume Injectable Formulations

    lipid nanoparticles in RNA therapies

    Lipid Nanoparticles in RNA and Gene Therapies

    Breast Cancer Therapy

    US FDA Approves Breast Cancer Therapy Inluriyo by Eli Lilly

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

United Cargo – after Opticooler RAP, now also Opticooler RKN certified

Content Team by Content Team
26th April 2023
in News, Packaging & Logistic
DoKaSch Temperature Solutions and Japan Airlines sign Master Rental Agreement

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

DoKaSch Temperature Solutions announced that United Cargo completed the technical approval of the Opticooler® RKN, to enhance their temperature-controlled airfreight transportation services catered primarily to the pharmaceutical industries’ global shipments.

On nearly all wide body international flights operated by United Airlines, shippers and forwarders worldwide can now draw upon the readily available and highly reliable temperature-controlled packaging solutions from DoKaSch-TS.

United Airlines and DoKaSch-TS maintain an established strong business relationship. United Cargo’s addition of the Opticooler® RKN to its product portfolio is another step to ensuring customer satisfaction in the U.S. market, where DoKaSch TS’s Opticooler® RAP is already well established.

Andreas Seitz, Managing Director of DoKaSch Temperature Solutions, adds that, “the technical approval of the Opticooler® RKN by United Cargo is a major step towards our growth strategy in the US. Thanks to this cooperation, we are further expanding our established and dispersed global network in the Americas and hence worldwide. With its market leading reliability as well as availability, our Opticooler® packaging solution will thereby become available to even more customers in the US as well as worldwide.”

“We have always focused on a strong cool chain packing solution within our network because the supply of lifesaving medicines is crucial. Thanks to direct connections to some of the most important hubs in the Western Hemisphere, we can provide highly reliable and quick transports to a wide variety of destinations,” said Manu Jacobs, Managing Director of Specialty Products at United Cargo. “The Opticoolers provided by DoKaSch Temperature Solutions are fulfilling our high standards and support our worldwide cool chain network network.”

The Opticooler® is a temperature-controlled packaging solution that comes in two sizes: the RAP container holds up to four CP 1 pallets (or five euro-pallets), while the smaller RKN version provides space for one CP 1 pallet (or any standard US pallet, up to max. 48 inches x 48 inches).

Both active cool chain containers are battery-powered, can easily be adapted to any transport scenario, and enable customers to always keep the desired temperature level. Since the Opticoolers require only a common power socket to be recharged, they can readily be used as temporary storage when the necessary infrastructure is lacking. This makes them the ideal solution for the safe transportation of highly sensitive pharmaceutical products which always need to be protected from the slightest temperature deviations.

Previous Post

New Approach Brought By Singapore For Pneumococcal Vaccines

Next Post

Malaria Immunity Boosted By Matrix-M, Saponin Based Adjuvant

Related Posts

idiopathic pulmonary fibrosis
Americas

US FDA Approves Jascayd for Idiopathic Pulmonary Fibrosis

9th October 2025
Tissue Repair Drug
Clinical Trials

FDA Clears Tissue Repair Drug AD-NP1 For Clinical Trials

7th October 2025
FastTrack Review
Americas

US FDA Launches Fast-Track Review Scheme for Generic Drugs

7th October 2025
AI Based Drug Discovery
Drug Development

Bristol Myers, Takeda, Astex to Back AI Based Drug Discovery

1st October 2025
API Manufacturing Facility
Americas

AbbVie Launches New API Manufacturing Facility in Illinois

1st October 2025
U.S. manufacturing
Americas

Amgen to Expand U.S. Manufacturing with $650M Investment

30th September 2025
Next Post
Tumors Can Get Destroyed By Bacteria-Aid To Immune System

Malaria Immunity Boosted By Matrix-M, Saponin Based Adjuvant

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In